Tango Therapeutics, Inc. (TNGX)Healthcare | Biotechnology | Boston, United States | NasdaqGM
26.64 USD
+1.60
(6.390%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 27.18 +0.54 (2.027%) ⇧ (April 17, 2026, 7:05 p.m. EDT) Short-term: ★★★★☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 10:42 p.m. EDT
TNGX presents a dangerous asymmetry suitable only for aggressive momentum traders. While fundamental metrics (negative EPS, massive cash burn, deteriorating revenue) clearly rate it a 0 for a long-term buy, the technical setup and sparse puts signaling extremely low downside risk in the immediate term. However, the 0.32% short ratio combined with management selling and a negative revenue growth rate suggests this rally is likely based on hype rather than sustainable business value accumulation. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.213372 |
| AutoARIMA | 0.306091 |
| AutoETS | 0.306092 |
| MSTL | 0.318239 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 40% |
| H-stat | 204.28 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.155 |
| Excess Kurtosis | -1.41 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 9.697 |
| Revenue per Share | 0.537 |
| Market Cap | 3,801,230,848 |
| Forward P/E | -16.65 |
| Beta | 1.32 |
| Profit Margins | -162.85% |
| Website | https://www.tangotx.com |
As of April 18, 2026, 10:42 p.m. EDT: Options flow shows a distinct bullish skew for the near term. At the May 15 expiration, there is significant volume at the 22.0 strike (110 contracts vs low Open Interest), indicating strong speculation of a move above current prices ($26.64), while ATM calls see high volume at 27.0. Conversely, put activity is sparse and concentrated deep out-of-the-money, with negligible expiration before 2026-11-20. The 2027-01-15 strikes show heavy OTM put positioning (240+ contracts at 17.0 strike on the open interest side), suggesting long-term downside insurance rather than immediate selling pressure, while no OTM calls exist on that front.
| Attribute | Value |
|---|---|
| 52 Week Change | 18.304348 |
| Address1 | 201 Brookline Avenue |
| Address2 | Suite 901 |
| All Time High | 26.81 |
| All Time Low | 1.03 |
| Ask | 26.84 |
| Ask Size | 27 |
| Audit Risk | 8 |
| Average Analyst Rating | 1.3 - Strong Buy |
| Average Daily Volume10 Day | 2,832,840 |
| Average Daily Volume3 Month | 3,239,264 |
| Average Volume | 3,239,264 |
| Average Volume10Days | 2,832,840 |
| Beta | 1.315 |
| Bid | 26.38 |
| Bid Size | 27 |
| Board Risk | 3 |
| Book Value | 2.547 |
| City | Boston |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 8 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 26.64 |
| Current Ratio | 16.318 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 26.81 |
| Day Low | 24.92 |
| Debt To Equity | 9.697 |
| Display Name | Tango Therapeutics |
| Earnings Timestamp | 1,772,717,400 |
| Earnings Timestamp End | 1,778,502,600 |
| Earnings Timestamp Start | 1,778,502,600 |
| Ebitda | -109,008,000 |
| Ebitda Margins | -1.74737 |
| Enterprise To Ebitda | -32.031 |
| Enterprise To Revenue | 55.97 |
| Enterprise Value | 3,491,663,104 |
| Eps Current Year | -1.33818 |
| Eps Forward | -1.6 |
| Eps Trailing Twelve Months | -0.87 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 17.0228 |
| Fifty Day Average Change | 9.617199 |
| Fifty Day Average Change Percent | 0.5649599 |
| Fifty Two Week Change Percent | 1,830.4348 |
| Fifty Two Week High | 26.81 |
| Fifty Two Week High Change | -0.17000008 |
| Fifty Two Week High Change Percent | -0.0063409205 |
| Fifty Two Week Low | 1.03 |
| Fifty Two Week Low Change | 25.609999 |
| Fifty Two Week Low Change Percent | 24.864077 |
| Fifty Two Week Range | 1.03 - 26.81 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,599,139,800,000 |
| Float Shares | 67,744,386 |
| Forward Eps | -1.6 |
| Forward P E | -16.65 |
| Free Cashflow | -60,859,624 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 137 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | -1.11857 |
| Gross Profits | -69,781,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0126600005 |
| Held Percent Institutions | 1.21253 |
| Implied Shares Outstanding | 142,688,851 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors, including TNG462, which is in Phase 1/2 clinical trial for treating pancreatic and lung cancer; and TNG456, a brain-penetrant PRMT5 inhibitor for the treatment of glioblastoma. It is developing TNG260, a co-repressor of repressor element-1 silencing transcription inhibitor to reverse the immune evasion effect of serine-threonine kinase (STK) 11 loss-of-function mutations to treat lung cancer. The company was founded in 2017 and is headquartered in Boston, Massachusetts. |
| Long Name | Tango Therapeutics, Inc. |
| Market | us_market |
| Market Cap | 3,801,230,848 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_424111353 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -101,594,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 3,801,230,990 |
| Number Of Analyst Opinions | 10 |
| Open | 25.31 |
| Operating Cashflow | -138,886,000 |
| Operating Margins | -1.7839301 |
| Overall Risk | 7 |
| Payout Ratio | 0.0 |
| Phone | 857 320 4900 |
| Post Market Change | 0.5400009 |
| Post Market Change Percent | 2.0270305 |
| Post Market Price | 27.18 |
| Post Market Time | 1,776,467,116 |
| Previous Close | 25.04 |
| Price Eps Current Year | -19.907637 |
| Price Hint | 2 |
| Price To Book | 10.459364 |
| Price To Sales Trailing12 Months | 60.932785 |
| Profit Margins | -1.62853 |
| Quick Ratio | 15.828 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.25 |
| Region | US |
| Regular Market Change | 1.6 |
| Regular Market Change Percent | 6.38977 |
| Regular Market Day High | 26.81 |
| Regular Market Day Low | 24.92 |
| Regular Market Day Range | 24.92 - 26.81 |
| Regular Market Open | 25.31 |
| Regular Market Previous Close | 25.04 |
| Regular Market Price | 26.64 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 2,781,109 |
| Return On Assets | -0.19451 |
| Return On Equity | -0.37235 |
| Revenue Growth | -1.0 |
| Revenue Per Share | 0.537 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 142,688,851 |
| Shares Percent Shares Out | 0.2829 |
| Shares Short | 40,370,279 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 48,739,116 |
| Short Name | Tango Therapeutics, Inc. |
| Short Percent Of Float | 0.32509997 |
| Short Ratio | 9.95 |
| Source Interval | 15 |
| State | MA |
| Symbol | TNGX |
| Target High Price | 30.0 |
| Target Low Price | 16.0 |
| Target Mean Price | 22.3 |
| Target Median Price | 20.5 |
| Total Cash | 343,137,984 |
| Total Cash Per Share | 2.405 |
| Total Debt | 33,570,000 |
| Total Revenue | 62,384,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.87 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 10.472175 |
| Two Hundred Day Average Change | 16.167824 |
| Two Hundred Day Average Change Percent | 1.543884 |
| Type Disp | Equity |
| Volume | 2,781,109 |
| Website | https://www.tangotx.com |
| Zip | 2,215 |